Sareum (LON:SAR) Stock Price Crosses Below 50-Day Moving Average – Here’s What Happened

Sareum Holdings plc (LON:SAR)’s share price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 26.09 ($0.32) and traded as low as GBX 22.25 ($0.28). Sareum shares last traded at GBX 23 ($0.28), with a volume of 182,731 shares trading hands.

Sareum Stock Performance

The company has a fifty day moving average price of GBX 26.09 and a 200-day moving average price of GBX 28.85. The firm has a market capitalization of £24.13 million, a PE ratio of -372.50 and a beta of -1.08.

Sareum Company Profile

Sareum is a specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases. The Company aims to generate value through licensing its candidates to international pharmaceutical and biotechnology companies at the preclinical or early clinical trials stage.
Sareum is advancing internal programmes focused on distinct dual tyrosine kinase 2 (TYK2) / Janus kinase 1 (JAK1) inhibitors through preclinical development as therapies for autoimmune diseases, including the ‘cytokine storm’ immune system overreaction to Covid-19 and other viral infections, (SDC-1801) and cancer immunotherapy (SDC-1802).
Sareum also has an economic interest in SRA737, a clinical-stage oral, selective Checkpoint kinase 1 (Chk1) inhibitor that targets cancer cell replication and DNA damage repair mechanisms.